This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vázquez-Talavera, J.
Right arrow Articles by Laclette, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vázquez-Talavera, J.
Right arrow Articles by Laclette, J. P.

 Previous Article  |  Next Article 

Infection and Immunity, September 2001, p. 5412-5416, Vol. 69, No. 9
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.9.5412-5416.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Characterization and Protective Potential of the Immune Response to Taenia solium Paramyosin in a Murine Model of Cysticercosis

José Vázquez-Talavera, Carlos F. Solís, Luis I. Terrazas, and Juan P. Laclette*

Department of Immunology, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, C.P. 04510, Mexico

Received 14 March 2001/Returned for modification 5 May 2001/Accepted 18 June 2001

Paramyosin has been proposed as a vaccine candidate in schistosomiasis and filariasis. However, limited information is available about its protective potential against cysticercosis and the immune response it induces. Immunization of mice with recombinant full-length paramyosin of Taenia solium (TPmy) results in about a 52% reduction in parasite burden after a subsequent challenge by intraperitoneal inoculation of Taenia crassiceps cysticerci. Immunization assays using recombinant fragments of TPmy, corresponding approximately to thirds on the amino, central, or carboxyl regions, suggest that protective epitopes are located mostly in the amino-end third. Proliferation assays using T cells obtained from mice immunized with the full-length recombinant TPmy also showed a preferential response to the amino-terminal fragment. In contrast, antibodies in the sera from these mice predominantly recognize epitopes located in the carboxyl-terminal fragment, being the immunoglobulin G1 subclass, the predominant antibody isotype. Characterization of the cellular immune response induced against the protective amino-terminal fragment reveals production of gamma interferon and interleukin-2, but not interleukin-4, suggesting a Th1-like profile.


* Corresponding author. Mailing address: Dirección, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, A.P. 70228, Ciudad Universitaria, C.P. 04510, Mexico City, Mexico. Phone: (525) 622-3862. Fax. (525) 550-6447. E-mail: laclette{at}servidor.unam.mx.


Infection and Immunity, September 2001, p. 5412-5416, Vol. 69, No. 9
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.9.5412-5416.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Hooper, S. L., Thuma, J. B. (2005). Invertebrate Muscles: Muscle Specific Genes and Proteins. Physiol. Rev. 85: 1001-1060 [Abstract] [Full Text]  
  • Solis, C. F., Ostoa-Saloma, P., Lugo-Martinez, V. H., Johnston, S. A., Laclette, J. P. (2005). Genetic Vaccination against Murine Cysticercosis by Using a Plasmid Vector Carrying Taenia solium Paramyosin. Infect. Immun. 73: 1895-1897 [Abstract] [Full Text]  
  • Deng, J., Gold, D., LoVerde, P. T., Fishelson, Z. (2003). Inhibition of the Complement Membrane Attack Complex by Schistosoma mansoni Paramyosin. Infect. Immun. 71: 6402-6410 [Abstract] [Full Text]